热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
APC anti-mouse CD3 Antibody
产品名称：
APC anti-mouse CD3 Antibody
产品类别：
抗体
产品编号：
100235
产品应用：
100235
[价格]
规格 价格 库存
25µg ￥ 396 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  2. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  2. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  3. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  4. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  5. Liu J, et al. 2019. Immunity. 50:600. PubMed
  6. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  7. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  8. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  9. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  10. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  11. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  12. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  13. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  14. Sano T, et al. 2021. Cell Reports. 36(8):109608. PubMed
  15. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  16. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  17. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  18. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  19. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  20. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  21. Baram T, et al. 2021. Cells. 10:. PubMed
  22. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  23. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  24. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  25. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  26. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  27. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  28. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  29. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  30. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  31. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  32. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  33. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  34. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  35. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  36. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  37. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  38. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  39. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  40. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  41. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  42. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  43. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  44. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  45. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  46. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  47. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  48. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  49. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  50. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  51. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  52. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  53. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  54. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  55. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  56. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  57. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  58. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  59. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  60. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  61. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  62. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  63. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  64. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  65. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  66. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  67. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  68. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  69. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  70. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  71. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  72. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  73. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  74. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  75. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  76. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  77. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  78. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  79. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  80. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  81. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  82. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  83. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  84. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  85. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  86. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  87. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  88. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  89. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  90. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  91. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  92. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  93. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  94. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  95. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  96. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  97. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  98. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  99. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  100. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  101. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  102. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  103. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  104. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  105. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  106. Zhang J, et al. 2018. Nature. 553:91. PubMed
  107. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  108. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  109. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  110. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  111. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  112. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  113. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  114. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  115. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  116. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  117. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  118. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  119. Kim S, et al. 2020. Autophagy. :1. PubMed
  120. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  121. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  122. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  123. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  124. Kelley WJ, et al. 2022. JCI Insight. :. PubMed
  125. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  126. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  127. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  128. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  129. Li H, et al. 2022. iScience. 25:104481. PubMed
  130. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  131. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  132. Zeng A, et al. 2020. Oncol Rep. . PubMed
  133. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  134. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  135. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  136. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  137. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  138. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  139. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  140. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  141. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  142. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  143. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  144. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  145. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  146. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  147. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  148. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  149. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
RRID
AB_2561455 (BioLegend Cat. No. 100235) AB_2561456 (BioLegend Cat. No. 100236)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线